|
Market Closed -
Nasdaq
04:00:00 2026-10-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 10.50 USD | -6.75% |
|
-10.79% | -33.04% |
| Oct. 01 | Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102 | CI |
| Oct. 01 | Monte Rosa Therapeutics, Inc. - Special Call |
| Market Cap | 896M 796M 743M 677M 1.28B 86.11B 1.29B 8.99B 3.48B 44.02B 3.36B 3.29B 141B | P/E 2026 * |
-7.1x | P/E 2027 * | -5.34x |
|---|---|---|---|---|---|
| Enterprise Value | 896M 796M 743M 677M 1.28B 86.11B 1.29B 8.99B 3.48B 44.02B 3.36B 3.29B 141B | EV / Sales 2026 * |
13.3x | EV / Sales 2027 * | 16.6x |
| Free-Float |
99.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GLUE | Delayed | |
CBOE
| GLUE | Real-time |
Last Transcript: Monte Rosa Therapeutics, Inc.
| 1 day | -6.75% | ||
| 1 week | -10.79% | ||
| Current month | -11.99% | ||
| 1 month | -26.16% | ||
| 3 months | -56.63% | ||
| 6 months | -38.56% | ||
| Current year | -33.04% |
| 1 week | 10.32 |  | 12.26 |
| 1 month | 10.32 | | 14.87 |
| Current year | 10.32 | | 25.77 |
| 1 year | 7.24 | | 25.77 |
| 3 years | 2.44 | | 25.77 |
| 5 years | 2.44 | | 27.56 |
| 10 years | 2.44 | | 45.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 55 | 2019-12-31 |
Magnus Walter
CTO | Chief Tech/Sci/R&D Officer | - | 2026-03-16 |
| Chief Operating Officer | 54 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Markus Warmuth
BRD | Director/Board Member | 55 | 2019-12-31 |
Ali Behbahani
BRD | Director/Board Member | 49 | 2020-03-31 |
| Director/Board Member | 57 | 2020-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/16/26 | Sell | Chief Executive Officer | -9,500 | 0.0112% | ||
| 7/15/26 | Exercice | Chief Operating Officer | 13,053 | 0.0155% | ||
| 7/6/26 | Exercice | Chief Technology Officer | 18,000 | 0.0213% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.75% | -10.79% | +37.61% | +132.30% | 896M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | -0.88% | -1.61% | +52.71% | +121.48% | 39.14B | |
| Weighted average by Cap. | +0.11% | -0.86% | +58.72% | +129.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.43M 59.91M 55.92M 50.97M 96.12M 6.48B 97.02M 677M 262M 3.31B 253M 248M 10.63B | 53.93M 47.92M 44.73M 40.77M 76.88M 5.18B 77.6M 541M 210M 2.65B 202M 198M 8.51B |
| Net income | -150M -133M -124M -113M -213M -14.38B -215M -1.5B -582M -7.35B -561M -549M -23.59B | -207M -184M -172M -157M -296M -19.93B -298M -2.08B -806M -10.19B -778M -761M -32.7B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | $10.50 | -6.75% | 2,214,535 |
| 26-10-01 | $11.26 | -5.62% | 2,868,605 |
| 26-09-30 | $11.93 | +1.62% | 913,958 |
| 26-09-29 | $11.74 | +0.26% | 545,067 |
| 26-09-28 | $11.71 | -0.51% | 772,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLUE Stock
Select your edition
All financial news and data tailored to specific country editions
